Caregiver, patient, Cofounder @Carestry_ working to improve family caregiving through tech, personalization and automation @MITSloan @NorthwesternU alum
Cambridge, MA
Joined June 2011
- Tweets2.7K
- Following465
- Followers1.4K
- Likes2.9K
Pinned Tweet
“I am a caregiver. I say that now and wish I’d said it sooner” — extremely empowering - thanks, @matt_perrin
Identifying as a #caregiver can bring benefits.
Here's @matt_perrin's take.
#caregiving #blog
buff.ly/3LAbAxO
Super interesting topic and a really insightful conversation. Highly recommend a listen - nice job @chrisleiter_
This quoted post is unavailable.
Josh Madej retweeted
In just five short months, #TBCPartner Rapport Tx has moved from stealth to a $150M Series B round, supporting its mission to tackle one of neuromedicine’s biggest challenges: to target specific parts of the brain for a more precise approach to treatment. bit.ly/3OH0s4C
Josh Madej retweeted
Congrats to new #TBCPartner @CerapedicsInc on announcing the expansion of its Denver area headquarters! The expansion will support the growth of its products, including FDA-approved i-FACTOR® bone graft, and its mission to repair bones & heal lives. bit.ly/43GwyTn
Josh Madej retweeted
#TBCPartner Tenpoint Therapeutics has a revolution in sight! Congrats to the team on launching today with a $70M Series A to transform the treatment of ocular diseases through vision-restoring engineered cell-based therapeutics and in vivo reprogramming: bit.ly/3pCqoWN
Josh Madej retweeted
We partnered with @C4Therapeutics to elevate their online presence & showcase their transformative work in targeted protein degradation (TPD). Check out the newly launched site, a hub of visually compelling content that explains the potential impact of TPD bit.ly/3piMsW7
Josh Madej retweeted
Congratulations to TBC partner @Sarepta on the approval of the first gene therapy for Duchenne muscular dystrophy. It is a pivotal moment for the DMD community in urgent need of new therapies. We’re proud to support this monumental advance for patients.
BREAKING: Today, we announced the @US_FDA approved our therapy to treat Duchenne muscular dystrophy, providing a new treatment option for this rare, degenerative disease. Learn more about this important milestone here: bit.ly/3JufCZg
Josh Madej retweeted
The Health Equity Report Card (HERC) contains 17 measurable actions to reduce disparities and #CloseTheCareGap for people with cancer. More information is coming on #WorldCancerDay, February 4: NCCN.org/wcd. (Image 15 of 17)
@NMQF @ACSCAN
This one hits close to home. After losing my mom to pancreatic cancer over two decades ago, it's great to see forward progress.
The 5-yr survival rate for #pancreaticcancer increased to 12% according to @AmericanCancer @NCICancerStats! For the first time since 2017, it's increased 2 years in a row. This promising trend points to continued progress in the fight against this disease. Let's keep going. 💜💪
Excited to join an amazing team doing such important work!
Join us in welcoming @JoshMadej as he joins TBC as VP, digital and social engagement. Josh brings a passion for caregivers and patients, and over 15 years of experience in digital and social strategy, execution and analytics across the healthcare space.
Josh Madej retweeted
Record-Breaking Gift this year of 69 millions for @PanMass #PMC22!!!
This brings the @PMC’s Total Contributions in Support of Cancer Research @DanaFarber to $900 Million since 1980!
@BillAlfano @starrpmc @jarrettcollins @RedSox @RedSoxFund @TheJimmyFund
Josh Madej retweeted
What a pleasure it was to share the stage with Medical Home Network to talk about #caregiving as a #sdoh.
Loved the energy at @camdenhealth's #CenteringCare22 🙌
#caregiversupport #healthequity
Josh Madej retweeted
Listen in as this pancreatic cancer power couple shares how they're fighting as a family while providing some great advice on the power of acceptance and how to support a cancer survivor as a friend and family member.
bit.ly/3PNdGfz
#beatpancreaticcancer
Josh Madej retweeted
Today, @ASCO & ACCC released resources to help research sites increase equity, diversity & inclusion in cancer #clinicaltrials & address barriers to participation.
- Just ASK™ Training Program & Guide
- Site Self-Assessment
Access both for free: bit.ly/2T7muV6 #ASCOACCC
Josh Madej retweeted
Dr. Susan Tsai discusses her research into the causes of pancreatic cancer surgery and treatment disparities for underserved communities. Click here to read: letswinpc.org/promising-scie…
ALT Dr. Susan Tsai wearing a grey jacket, and white shirt against a white background.
Josh Madej retweeted
🎙 On this week's Project Purple Podcast we hear from Dr. Michael Pishvaian of Johns Hopkins, who shares his unique perspective on the treatment of pancreatic cancer and life-saving research. Check out the episode:
apple.co/382dUyB
Josh Madej retweeted
Hey @LinkedIn, thanks for this!
Hey family #caregivers, heads-up that you can now add 'career break' *and* specify #caregiving on your LinkedIn profile.
Sweet!
buff.ly/3tGv4Jb
Josh Madej retweeted
.@LolaRahib and Patrick van der Valk explain how @CancerCommons and @xCures are using real-world data to improve care for future patients. letswinpc.org/promising-scie…
Josh Madej retweeted
Technology for technology's sake doesn't do us any good.
Especially when it comes to supporting #caregivers.